Immunofluorescence of immunoglobulins and complement in kidneys taken at necropsy
- PMID: 2685055
- PMCID: PMC501984
- DOI: 10.1136/jcp.42.11.1211
Immunofluorescence of immunoglobulins and complement in kidneys taken at necropsy
Abstract
The immunofluorescence of immunoglobulins and complement components in kidney specimens taken at necropsy was investigated to determine the persistence of antigenicity of immune reactants. Of 74 consecutive necropsies, 12 cases had positive glomerular fluorescence. The pattern and intensity were followed up for up to 15 days. Along with necropsy specimens, tissue samples of normal looking kidney from 14 nephrectomies were also studied. Two of these specimens turned out to be positive in the immediate immunofluorescence study. To rule out possible false positive staining after death immunofluorescence findings in all nephrectomy specimens were followed up for up to 19 days. The presence of immunoglobulins and complement could be shown for between 12 and 15 days after death; no changes in immunofluorescence findings occurred during this period. It is concluded that immunofluorescence provides valuable information when immunologically mediated reactions need to be clarified in necropsy kidneys.
Similar articles
-
Immunopathology of the end-stage kidney. Immunoglobulin and complement component deposition in nonimmune disease.Am J Pathol. 1976 Jul;84(1):149-62. Am J Pathol. 1976. PMID: 779494 Free PMC article. Clinical Trial.
-
Immunofluorescence staining for the detection of immunoglobulins and complement (C3) in dogs with renal disease.Vet Rec. 2008 Dec 6;163(23):679-82. Vet Rec. 2008. PMID: 19060316
-
Immunofluorescence studies of dense deposit disease. The presence of railroad tracks and mesangial rings.Lab Invest. 1979 Apr;40(4):474-80. Lab Invest. 1979. PMID: 372673
-
Interpretation of immunofluorescent patterns in renal diseases.Pathobiol Annu. 1980;10:183-221. Pathobiol Annu. 1980. PMID: 7003493 Review. No abstract available.
-
Direct immunofluorescence patterns in clinically healthy skin of patients with collagen diseases.Clin Dermatol. 1992 Oct-Dec;10(4):423-30. doi: 10.1016/0738-081x(92)90088-g. Clin Dermatol. 1992. PMID: 1303807 Review. No abstract available.
Cited by
-
Significance of Glomerular Immune Reactivity in Time Zero Biopsies for Allograft Survival Beyond IgA.Front Med (Lausanne). 2021 Apr 6;8:656840. doi: 10.3389/fmed.2021.656840. eCollection 2021. Front Med (Lausanne). 2021. PMID: 33889588 Free PMC article.
-
New developments in the genetics, pathogenesis, and therapy of IgA nephropathy.Kidney Int. 2015 Nov;88(5):974-89. doi: 10.1038/ki.2015.252. Epub 2015 Sep 16. Kidney Int. 2015. PMID: 26376134 Free PMC article. Review.
-
Maternally inherited diabetes and deafness complicated by mesangial galactose-deficient IgA1 deposits: a case report.BMC Nephrol. 2018 Dec 10;19(1):350. doi: 10.1186/s12882-018-1152-6. BMC Nephrol. 2018. PMID: 30526529 Free PMC article.
-
A 25-year experience with pediatric anti-glomerular basement membrane disease.Pediatr Nephrol. 2011 Jan;26(1):85-91. doi: 10.1007/s00467-010-1663-2. Epub 2010 Oct 21. Pediatr Nephrol. 2011. PMID: 20963446
-
Candidate Urine Peptide Biomarkers for IgA Nephropathy: Where Are We Now?Dis Markers. 2018 Jan 21;2018:5205831. doi: 10.1155/2018/5205831. eCollection 2018. Dis Markers. 2018. PMID: 29606986 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources